Latest Tavr News

Page 2 of 2

Anteris Launches Global Trial for Innovative DurAVR Heart Valve

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

Ada Torres

16 Oct 2025

Browse the archive

Full archive

Nov 2026 Oct 2026 Sept 2026 Aug 2026 July 2026 June 2026 May 2026 Apr 2026

Top